272 related articles for article (PubMed ID: 19118018)
21. Sorafenib inhibits endogenous and IL-6/S1P induced JAK2-STAT3 signaling in human neuroblastoma, associated with growth suppression and apoptosis.
Yang F; Jove V; Buettner R; Xin H; Wu J; Wang Y; Nam S; Xu Y; Ara T; DeClerck YA; Seeger R; Yu H; Jove R
Cancer Biol Ther; 2012 May; 13(7):534-41. PubMed ID: 22406995
[TBL] [Abstract][Full Text] [Related]
22. Discrepancy of biologic behavior influenced by bone marrow derived cells in lung cancer.
Zhang J; Niu XM; Liao ML; Liu Y; Sha HF; Zhao Y; Yu YF; Tan Q; Xiang JQ; Fang J; Lv DD; Li XB; Lu S; Chen HQ
Oncol Rep; 2010 Nov; 24(5):1185-92. PubMed ID: 20878109
[TBL] [Abstract][Full Text] [Related]
23. STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma.
Tu B; Du L; Fan QM; Tang Z; Tang TT
Cancer Lett; 2012 Dec; 325(1):80-8. PubMed ID: 22743617
[TBL] [Abstract][Full Text] [Related]
24. [CD40 ligandization promotes IL-6 and Flt3 ligand production of bone marrow stromal cells].
Fu J; Liu Y; Zhang X
Zhonghua Xue Ye Xue Za Zhi; 2002 Nov; 23(11):585-7. PubMed ID: 12482343
[TBL] [Abstract][Full Text] [Related]
25. Calcium phosphate scaffolds with defined interconnecting channel structure provide a mimetic 3D niche for bone marrow metastasized tumor cell growth.
Aveic S; Davtalab R; Vogt M; Weber M; Buttler P; Tonini GP; Fischer H
Acta Biomater; 2019 Apr; 88():527-539. PubMed ID: 30797105
[TBL] [Abstract][Full Text] [Related]
26. [Research Progress on Effect of Bone Marrow Microenvironment Regulated by IL-6/IL-6R/JAK2/STAT3 Pathway on Biological Behavior of Multiple Myeloma--Review].
Shi YS; Xu JW; Liu QQ; Li YQ; Cheng WM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):318-321. PubMed ID: 38387942
[TBL] [Abstract][Full Text] [Related]
27. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6.
Tamura T; Udagawa N; Takahashi N; Miyaura C; Tanaka S; Yamada Y; Koishihara Y; Ohsugi Y; Kumaki K; Taga T
Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11924-8. PubMed ID: 8265649
[TBL] [Abstract][Full Text] [Related]
28. Direct crosstalk between cancer and osteoblast lineage cells fuels metastatic growth in bone via auto-amplification of IL-6 and RANKL signaling pathways.
Zheng Y; Chow SO; Boernert K; Basel D; Mikuscheva A; Kim S; Fong-Yee C; Trivedi T; Buttgereit F; Sutherland RL; Dunstan CR; Zhou H; Seibel MJ
J Bone Miner Res; 2014 Sep; 29(9):1938-49. PubMed ID: 24676805
[TBL] [Abstract][Full Text] [Related]
29. A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma.
Geminder H; Sagi-Assif O; Goldberg L; Meshel T; Rechavi G; Witz IP; Ben-Baruch A
J Immunol; 2001 Oct; 167(8):4747-57. PubMed ID: 11591806
[TBL] [Abstract][Full Text] [Related]
30. Transformation potential of bone marrow stromal cells into undifferentiated high-grade pleomorphic sarcoma.
Li Q; Hisha H; Takaki T; Adachi Y; Li M; Song C; Feng W; Okazaki S; Mizokami T; Kato J; Inaba M; Hosaka N; Maki M; Ikehara S
J Cancer Res Clin Oncol; 2010 Jun; 136(6):829-38. PubMed ID: 19936790
[TBL] [Abstract][Full Text] [Related]
31. Stimulation of calvarial bone healing with human bone marrow stromal cells versus inhibition with adipose-tissue stromal cells on nanostructured β-TCP-collagen.
Bothe F; Lotz B; Seebach E; Fischer J; Hesse E; Diederichs S; Richter W
Acta Biomater; 2018 Aug; 76():135-145. PubMed ID: 29933108
[TBL] [Abstract][Full Text] [Related]
32. Activation of IL-6R/JAK1/STAT3 signaling induces de novo resistance to irreversible EGFR inhibitors in non-small cell lung cancer with T790M resistance mutation.
Kim SM; Kwon OJ; Hong YK; Kim JH; Solca F; Ha SJ; Soo RA; Christensen JG; Lee JH; Cho BC
Mol Cancer Ther; 2012 Oct; 11(10):2254-64. PubMed ID: 22891040
[TBL] [Abstract][Full Text] [Related]
33. Histopathologic analysis of bone marrow and bone metastasis in murine neuroblastoma.
Yoshino K; Tanabe M; Ohnuma N; Takahashi H
Clin Exp Metastasis; 1996 Oct; 14(5):459-65. PubMed ID: 8871540
[TBL] [Abstract][Full Text] [Related]
34. Effect of interleukin-6 secreted by engineered human stromal cells on osteoclasts in human bone.
Sandhu JS; Gorczynski RM; Waddell J; Nguyen H; Squires J; Waddell J; Boynton EL; Hozumi N
Bone; 1999 Mar; 24(3):217-27. PubMed ID: 10071914
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-6 in bone metastasis and cancer progression.
Ara T; Declerck YA
Eur J Cancer; 2010 May; 46(7):1223-31. PubMed ID: 20335016
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-18 produced by bone marrow-derived stromal cells supports T-cell acute leukaemia progression.
Uzan B; Poglio S; Gerby B; Wu CL; Gross J; Armstrong F; Calvo J; Cahu X; Deswarte C; Dumont F; Passaro D; Besnard-Guérin C; Leblanc T; Baruchel A; Landman-Parker J; Ballerini P; Baud V; Ghysdael J; Baleydier F; Porteu F; Pflumio F
EMBO Mol Med; 2014 Jun; 6(6):821-34. PubMed ID: 24778454
[TBL] [Abstract][Full Text] [Related]
37. Synergy between IL-6 and soluble IL-6 receptor enhances bone morphogenetic protein-2/absorbable collagen sponge-induced bone regeneration via regulation of BMPRIA distribution and degradation.
Huang RL; Chen G; Wang W; Herller T; Xie Y; Gu B; Li Q
Biomaterials; 2015 Oct; 67():308-22. PubMed ID: 26232880
[TBL] [Abstract][Full Text] [Related]
38. Role of mitogen-activated protein kinase family in serum-induced leukaemia inhibitory factor and interleukin-6 secretion by bone marrow stromal cells.
Nakao T; Kim S; Ohta K; Kawano H; Hino M; Miura K; Tatsumi N; Iwao H
Br J Pharmacol; 2002 Aug; 136(7):975-84. PubMed ID: 12145097
[TBL] [Abstract][Full Text] [Related]
39. Expression levels of gp130 in bone marrow stromal cells determine the magnitude of osteoclastogenic signals generated by IL-6-type cytokines.
O'Brien CA; Lin SC; Bellido T; Manolagas SC
J Cell Biochem; 2000 Sep; 79(4):532-41. PubMed ID: 10996844
[TBL] [Abstract][Full Text] [Related]
40. CXCR4 expression in neuroblastoma primary tumors is associated with clinical presentation of bone and bone marrow metastases.
Russell HV; Hicks J; Okcu MF; Nuchtern JG
J Pediatr Surg; 2004 Oct; 39(10):1506-11. PubMed ID: 15486895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
